| Robert H Beaty, MD | |
|
100 Broad St, Glens Falls, NY 12801-4349 | |
| (518) 792-2223 | |
| (518) 792-8231 |
| Full Name | Robert H Beaty |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 100 Broad St, Glens Falls, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316951031 | NPI | - | NPPES |
| 01046542 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 171995 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert H Beaty, MD 9 Carey Rd, Queensbury, NY 12804-7880 Ph: (518) 761-0300 | Robert H Beaty, MD 100 Broad St, Glens Falls, NY 12801-4349 Ph: (518) 792-2223 |
News Archive
Is it possible to create a truly bushfire-resistant house? What's the best way to donate to bushfires? How can you tell fact from fake news in this era of Twitter bots? How can we improve communication to save lives and property? These and more questions will be on the table at an important forum at QUT this Friday addressing Australia's catastrophic fire season.
Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).
Montreux Equity Partners, LLC, and GC Aesthetics, Ltd., today announced the completion of a US$30 million private equity investment by Montreux into GCAL. GCAL is a leading designer, manufacturer, and distributor of medical devices for the global aesthetics industry. Montreux entered into the financing agreement with GCAL to accelerate the company's expansion plans.
For the first time, researchers have found a way to inject a precise dose of a gene therapy agent directly into a single living cell without a needle.
A study shows that stimulating the production of interleukin-17A (IL-17A), one of the cytokines released by cells of the immune system, can be an effective strategy for the treatment of visceral leishmaniasis, considered one of the six most important parasitic diseases affecting humans.
› Verified 9 days ago
Dr. Andrew W. Garner, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8 Harrison Ave, Glens Falls, NY 12801 Phone: 518-798-9401 | |
Dr. Diane Marie Macdonnell, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 461 Glen St, Glens Falls, NY 12801 Phone: 518-745-5889 Fax: 518-745-0010 | |
Michael Gumuka, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Broad St, Glens Falls, NY 12801 Phone: 518-792-2223 Fax: 518-792-8231 | |
Dr. Jill S Adelman, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Broad St, Glens Falls, NY 12801 Phone: 518-792-2223 Fax: 518-792-8231 | |
Dr. Craig Alan Emblidge, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3 Irongate Center, Glens Falls, NY 12801 Phone: 518-793-4409 Fax: 518-793-5886 | |
James C Hicks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Broad St, Glens Falls, NY 12801 Phone: 518-792-2223 Fax: 518-792-8231 |